Diagnosis of tuberculosis in pleural effusion of lung tumor patients using adenosine deaminase test
Keywords:
adenosine deaminase, lung tumors, pleural effusion, tuberculosisAbstract
Background and aim: Tuberculosis (TB) remains a global burden and presents challenges both in diagnosis and treatment, primarily when focusing on the association between pleural effusion, lung tumors, and TB. This study aimed to evaluate the efficacy of adenosine deaminase (ADA) as a non-invasive diagnostic tool for TB in pleural effusion among patients with lung tumors. Given the limitations of sputum culture, the study emphasizes the need for standardized diagnostic approaches, particularly in endemic regions such as Indonesia. Methods: The study includes 79 subjects with primary lung tumors and pleural effusion. Sample collection employed consecutive sampling, with pleural fluid samples obtained from hospitalized individuals. Laboratory tests were conducted using the ELISA method. Statistical analysis, using SPSS version 26, employed a descriptive approach to analyze the research data, with a level of statistical significance set at a P value of <0.05. Results: The study established an ADA cut-off of ≥34 IU/L for tuberculosis diagnosis, exhibiting excellent discrimination (AUC: 98.8%) and a sensitivity of 87.5% with 95.8% specificity. The positive and negative predictive values were 70% and 98.55%, respectively. These results support ADA's efficacy in predicting TB in lung tumor patients with pleural effusion, with considerations for potential biases in comorbid conditions and intensive TB treatment. Conclusions: ADA is a reliable diagnostic marker for TB in lung tumor patients with pleural effusion, underscoring its clinical utility in TB diagnosis. The findings emphasize ADA's significance in discriminating TB status, offering valuable insights for clinical decision-making in similar patient populations.
References
Iskandar D, Suwantika AA, Pradipta IS, Postma MJ, van Boven JFM. Clinical and economic burden of drug-susceptible tuberculosis in Indonesia: national trends 2017–19. Lancet Glob Health. 2023 Jan 1;11(1):117–25. doi: 10.1016/S2214-109X(22)00455-7
Glaziou P, Floyd K, Raviglione MC. Global epidemiology of tuberculosis. Semin Respir Crit Care Med. 2018;39(3):271–85. doi: 10.1055/s-0038-1651492
Skok K, Hladnik G, Grm A, Crnjac A. Malignant pleural effusion and its current management: A review. Vol. 55, Medicina (Lithuania). MDPI AG; 2019. p. 1–21. doi: 10.3390/medicina55080490
Koegelenberg CFN, Shaw JA, Irusen EM, Lee YCG. Contemporary best practice in the management of malignant pleural effusion. Vol. 12, Ther. Adv. Respir. Dis. 2018. p. 1–13. doi: 10.1177/1753466618785098
Jovanovic D. Etiopathogenesis of malignant pleural effusion. AME Med. J. 2021;6: 1–7. doi: 10.21037/amj-2019-mpe-05
Chen Y, Mathy NW, Lu H. The role of VEGF in the diagnosis and treatment of Malignant pleural effusion in patients with non-small cell lung cancer (review). Mol. Med. Rep. 2018;17: 8019–30. doi: 10.3892/mmr.2018.8922
Cicenas S, Vencevičius V. Lung cancer in patients with tuberculosis. World J Surg Oncol. 2007;5(22). doi: 10.1186/1477-7819-5-22
Çakar B, Çiledağ A. Evaluation of coexistence of cancer and active tuberculosis; 16 case series. Respir. Med. Case. Rep. 2018 Jan 1;23:33–7. doi: 10.1016/j.rmcr.2017.11.004
Wu CY, Hu HY, Pu CY, et al. Pulmonary tuberculosis increases the risk of lung cancer. Cancer. 2011 Feb 1;117(3):618–24. doi: 10.1002/cncr.25616
Yu YH, Liao CC, Hsu WH, et al. Increased lung cancer risk among patients with pulmonary tuberculosis: A population cohort study. J Thorac Oncol. 2011 Jan 1;6(1):32–7. doi: 10.1097/JTO.0b013e3181fb4fcc
Oh CM, Roh YH, Lim D, et al. Pulmonary tuberculosis is associated with elevated risk of Lung cancer in Korea: the nationwide cohort study. J Cancer. 2020;11(7):1899–906. doi: 10.7150/jca.37022
Suzuki Y, Imokawa S, Sato J, Uto T, Suda T. Cumulative incidence of tuberculosis in lung cancer patients in Japan: A 6-year observational study. Respir Investig. 2016 May 1;54(3):179–83. doi: 10.1016/j.resinv.2015.11.001
Kim HW, Kim KH, Shin AY, et al. Investigating the appropriate adenosine deaminase cutoff value for the diagnosis of tuberculous pleural effusion in a country with decreasing TB burden. Sci Rep. 2022 May 9;12(1):1–13. doi: 10.1038/s41598-022-11460-w
Barua R, Hossain M. Adenosine deaminase in diagnosis of tuberculosis: a review. Anwer Khan Modern Medical College Journal. 2014 Dec 3;5(2):43–8. doi: 10.3329/akmmcj.v5i2.21132
Palma RM, Bielsa S, Esquerda A, Martínez-Alonso M, Porcel JM. Diagnostic accuracy of pleural fluid adenosine deaminase for diagnosing tuberculosis. Meta-analysis of Spanish studies. Arch. Bronconeumol. (English Edition). 2019 Jan 1;55(1):23–30. doi: 10.1016/j.arbres.2018.05.007
Gopi A, Madhavan SM, Sharma SK, Sahn SA. Diagnosis and treatment of tuberculous pleural effusion in 2006. Chest. 2007 Mar 1;131(3):880–9. doi: 10.1378/chest.06-2063
Michot JM, Madec Y, Bulifon S, et al. Adenosine deaminase is a useful biomarker to diagnose pleural tuberculosis in low to medium prevalence settings. Diagn Microbiol Infect Dis. 2016 Mar 1;84(3):215–20. doi: 10.1016/j.diagmicrobio.2015.11.007
Amalia RN, Pradjoko I. The value of adenosine deaminase (ADA) of pleural fluid in tuberculosis patient. J Respir. 2016;2(2):35–40. doi: 10.20473/jr.v2-I.2.2016.35-40
Rosfadilla P, Widirahardjo, Syarani F, Mutiara E. Diagnostic accuracy of pleural fluid adenosine deaminase level test in tuberculous pleural effusion. J Respir Indo. 2017;37(4):278–82. doi: 10.36497/jri.v37i4.81
Horton KC, MacPherson P, Houben RMGJ, White RG, Corbett EL. Sex differences in tuberculosis burden and notifications in low- and middle-income countries: a systematic review and meta-analysis. PLoS Med. 2016 Sep 1;13(9):1–23. doi: 10.1371/journal.pmed.1002119
Marçôa R, Ribeiro A, Zão I, Duarte R. Tuberculosis and gender – Factors influencing the risk of tuberculosis among men and women by age group. Pulmonology. 2018;24(3):199–202. doi: 10.1016/j.pulmoe.2018.03.004
Huan NC, Khor IS, Ramarmuty HY, et al. Optimizing the utility of pleural fluid adenosine deaminase for the diagnosis of tuberculous pleural effusion. Proc. Singapore Healthc. 2021 Dec 1;30(4):271–8. doi: 10.1177/20101058209789
Reechaipichitkul W, Suleesathire T, Chaimanee P. Comparison of GeneXpert MTB/RIF assay with conventional AFB smear for diagnosis of pulmonary tuberculosis in northeastern Thailand. Southeast Asian J Trop Med Public Health. 2017;48(2):313–21. PMID: 29641882
Agarwal L, Garg A, Gupta M, Mathur R. A Prospective Study for comparison of diagnostic utility of Gene XPERT MTB/RIF Assay, adenosine deaminase and cytology in Tuberculous Pleural Effusion. IP Arch Cytol Histopathol Res. 2020 Oct 28;5(3):194–8. doi: 10.18231/j.achr.2020.043
Djannah F, Massi MN, Hatta M, Bukhari A, Hasanah I. Profile and histopathology features of top three cases of Extra Pulmonary Tuberculosis (EPTB) in West Nusa Tenggara: A retrospective cross-sectional study. Ann. Med. Surg. 2022 Mar 1;75:103318. doi: 10.1016/j.amsu.2022.103318
Villena V, Navarro-Gonzálvez J, García-Benayas C, et al. Rapid automated determination of adenosine deaminase and lysozyme for differentiating tuberculous and nontuberculous pleural effusions. Clin Chem. 1996;42(2):218–21. doi: 10.1093/clinchem/42.2.218
Piras MA, Gakis C, Budroni M, Andreoni G. Adenosine deaminase activity in pleural effusions: an aid to differential diagnosis. Br Med J. 1978 Dec 12;2(6154):1751–2. doi: 10.1136/bmj.2.6154.1751-a
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Muh. Dinul Fazmar, Muh. Ilyas, Agus Sudarso, Syakib Bakri, Suriani Alimuddin, Andi Alfian Zainuddin
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
How to Cite
